Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial.
Sign Up to like & getrecommendations! Published in 2020 at "European journal of cancer"
DOI: 10.1016/j.ejca.2020.05.007
Abstract: BACKGROUND Luminal A-like and luminal B-like subtypes have different sensitivity to (neo)adjuvant chemotherapy, but their role in predicting dose-dense (DD) efficacy in the high-risk setting is unknown. In this exploratory analysis of the Gruppo Italiano… read more here.
Keywords: chemotherapy; gim2 trial; like cohort; luminal like ... See more keywords
Real-World Patient Characteristics and Treatment Outcomes for Multiple Myeloma in Dreamm-7 and Dreamm-8 Cohorts in Finland
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-209552
Abstract: Introduction: Belantamab mafodotin (belamaf) is a novel treatment option for advanced multiple myeloma (MM), for which numerous clinical trials are ongoing. This population-based study aimed to describe the characteristics and treatment outcomes of MM patients,… read more here.
Keywords: dreamm; treatment; like cohort; dreamm dreamm ... See more keywords